News

Zevia's Stock Faces Major Decline Amid Q4 Loss Update

Zevia's Stock Faces Major Decline Amid Q4 Loss Update

Zevia's Stock Reaction to Q4 Projections

Recently, Zevia PBC faced considerable turbulence in its stock market performance, witnessing a notable decline of up to 19% during intraday trading. This marked the most significant drop since mid-November and has raised concerns among investors.

Reasons Behind the Stock Drop

The steep fall in share price followed the company's announcement regarding its revised projections for the fourth quarter. Zevia indicated that its adjusted EBITDA loss would be larger than initially estimated. The company attributed this adjustment to increased investments in its marketing efforts during the holiday season.

Sales Forecasts

As part of its revised guidance, Zevia anticipates net sales for the fourth quarter to reach approximately $39.5 million. This figure fits within the company’s previous projections, which ranged from $38 million to $40 million, suggesting some stability in their sales expectations despite the loss revisions.

Adjusted EBITDA Loss Adjustments

However, the updated outlook has also revealed a concerning rise in the expected adjusted EBITDA loss for Q4. The revised range now stands between $3.9 million and $4.2 million, a significant increase from the earlier prediction which estimated losses between $1.8 million and $2.2 million. This adjustment has undoubtedly shaken investor confidence.

Looking Ahead to 2024

Despite the recent downturn, Zevia has shared its outlook for 2024. The company forecasts net sales to be around $155 million, consistent with its earlier outlook that estimated figures between $154 million and $156 million. This projection offers a glimmer of hope that the company can stabilize and grow its revenue.

Future Adjusted EBITDA Loss Expectations

On a more sobering note, Zevia warns that the adjusted EBITDA loss anticipated for 2024 may expand further, with estimates ranging between $15.2 million and $15.5 million. This anticipated loss underscores the significant challenges facing Zevia as it navigates competitive market dynamics and plans for strategic growth.

Company Contact Information

For further inquiries or additional information regarding Zevia PBC, feel free to reach out through the company's official channels.

Frequently Asked Questions

What caused Zevia's stock price to drop recently?

Zevia's stock price dropped due to revised projections indicating a larger than expected adjusted EBITDA loss for Q4, influenced by increased marketing investments.

What are Zevia's expected net sales for Q4?

The company expects fourth-quarter net sales to be around $39.5 million, aligning with previous estimates.

How much is Zevia expecting to lose in adjusted EBITDA for Q4?

Zevia projects its adjusted EBITDA loss for Q4 to be between $3.9 million and $4.2 million, a notable increase from earlier predictions.

What is Zevia’s sales forecast for 2024?

For 2024, Zevia expects net sales of approximately $155 million, maintaining its prior range forecast.

What loss is Zevia anticipating for adjusted EBITDA in 2024?

The expected adjusted EBITDA loss for 2024 is projected to be between $15.2 million and $15.5 million, indicating financial challenges ahead.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Real-Time Video Solutions with Haivision on AWS

Updated Category News Views 90

Haivision StreamHub and MoJoPro Revolutionize Mobile Broadcasting Haivision Systems Inc. (TSX: HAI), a leader in real-time video networking, has launched an innovative mobile broadcasting solution. Now available on the AWS Marketplace, the pairing of Haivision StreamHub with the MoJoPro app changes the game for journalists, video professionals, and broadcasters. They can...

Continue Reading
Keurig Dr Pepper's Strategic Acquisition Plans for JDE Peet's

Updated Category News Views 298

Keurig Dr Pepper's Strategic Acquisition Plans for JDE Peet's In a noteworthy announcement, Keurig Dr Pepper Inc. (NASDAQ: KDP) and JDE Peet's N.V. are making headlines with their plans regarding a public offer. This joint statement serves to inform stakeholders about the progress on KDP's intended recommended public offer for all outstanding shares of JDE Peet's. Basis...

Continue Reading
Join Wreaths Across America: Make a Difference This Season

Updated Category News Views 93

Join Wreaths Across America This December This December, Wreaths Across America (WAA), a national nonprofit, is gearing up for a meaningful wreath season. With over 20 new loads in need of carrier support, WAA is on the lookout for dedicated carriers and professional drivers who want to take part in its mission to Remember, Honor, and Teach. This initiative is set to...

Continue Reading
iMD Companies to Introduce New Product Line for Supplements

Updated Category News Views 159

iMD Companies and Riize Health Launch New Supplements iMD Companies, Inc. (OTC: ICBU) and its subsidiary, Riize LLC, are making waves in the health sector by introducing three new non-prescription products designed for online and retail distribution. The launch is set for the first quarter of the upcoming year and aims to cater directly to consumer needs in the...

Continue Reading
Activist Investors Surge: A Look into 2025's Landscape

Updated Category News Views 1737

Activist Investors Surge in 2024 By Svea Herbst-Bayliss A remarkable shift occurred in 2024 as a record number of activist shareholders launched campaigns aimed at global companies. Recent reports highlight that tactics employed by these shareholders have yielded impressive returns, which suggests a continued rise in these activities as we progress into the future. Rising...

Continue Reading